心不全治療薬市場：治療（医療機器、医薬品、手術）、タイプ（診断、予後）、ステージ、エンドユーザー別-2023-2030年の世界予測

心不全治療薬の世界市場は、2023年にCAGR 10.23%で239億8,000万米ドル、2030年には481億3,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の心不全治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.心不全治療薬の世界市場規模および予測は？

2.予測期間中、世界の心不全治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.心不全治療薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.心不全治療薬の世界市場における競争戦略は？

5.心不全治療薬の世界市場における技術動向と規制の枠組みは？

6.心不全治療薬の世界市場における主要ベンダーの市場シェアは？

7.心不全治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口における心血管疾患の有病率の上昇
    • ライフスタイルの変化により心不全や不整脈になりやすくなる
    • 心不全の早期診断と管理の利用可能性と優先度
  • 抑制要因
    • 心不全治療に関連する高額な費用と償還の問題
  • 機会
    • 心不全治療薬の革新と発展
    • 政府による継続的な取り組みと民間部門による投資の増加
  • 課題
    • 心不全状態の管理に関する懸念
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 心不全治療薬市場治療別

• 医療機器
  • バイレベル陽圧装置
  • 両心室ペースメーカー
  • 連続陽圧装置
  • 心臓ポンプ
  • 植込み型除細動器
  • 植込み型左心室補助装置
• 薬
  • アンジオテンシンII受容体遮断薬
  • 抗凝固薬
  • 抗血小板薬
  • 血圧維持剤
  • 利尿薬
  • 硝酸塩
  • スタチン
• 手術
  • 心臓の再同期
  • 冠動脈バイパス移植術
  • 冠動脈血行再建術
  • 心臓移植
  • 心臓弁置換術

第7章 心不全治療薬市場：タイプ別

• 診断
• 予後

第8章 心不全治療薬市場：ステージ別

• ステージA
• ステージB
• ステージC
• ステージD

第9章 心不全治療薬市場：エンドユーザー別

• 診療所
• 病院
• 医学調査機構

第10章 南北アメリカの心不全治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の心不全治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの心不全治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. HEART FAILURE THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. HEART FAILURE THERAPEUTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
• FIGURE 5. HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2022 VS 2030 (%)
• FIGURE 7. HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 8. HEART FAILURE THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. HEART FAILURE THERAPEUTICS MARKET DYNAMICS
• FIGURE 10. HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. HEART FAILURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. HEART FAILURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HEART FAILURE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 5. HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 6. HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HEART FAILURE THERAPEUTICS MARKET SIZE, BY BI-LEVEL POSITIVE AIR PRESSURE DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. HEART FAILURE THERAPEUTICS MARKET SIZE, BY BIVENTRICULAR PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. HEART FAILURE THERAPEUTICS MARKET SIZE, BY CONTINUOUS POSITIVE AIR PRESSURE DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. HEART FAILURE THERAPEUTICS MARKET SIZE, BY HEART PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. HEART FAILURE THERAPEUTICS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. HEART FAILURE THERAPEUTICS MARKET SIZE, BY IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 14. HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. HEART FAILURE THERAPEUTICS MARKET SIZE, BY ANGIOTENSIN II RECEPTOR BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. HEART FAILURE THERAPEUTICS MARKET SIZE, BY ANTICOAGULANT MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. HEART FAILURE THERAPEUTICS MARKET SIZE, BY ANTIPLATELET MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. HEART FAILURE THERAPEUTICS MARKET SIZE, BY BLOOD PRESSURE MAINTAINING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. HEART FAILURE THERAPEUTICS MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. HEART FAILURE THERAPEUTICS MARKET SIZE, BY NITRATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STATINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 23. HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. HEART FAILURE THERAPEUTICS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. HEART FAILURE THERAPEUTICS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. HEART FAILURE THERAPEUTICS MARKET SIZE, BY CORONARY REVASCULARIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. HEART FAILURE THERAPEUTICS MARKET SIZE, BY HEART TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. HEART FAILURE THERAPEUTICS MARKET SIZE, BY HEART VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. HEART FAILURE THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. HEART FAILURE THERAPEUTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 33. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE D, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. HEART FAILURE THERAPEUTICS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. HEART FAILURE THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 64. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 65. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 66. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 67. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 69. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 101. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 103. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 104. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 106. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 108. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 110. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 111. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 113. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 155. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 162. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 169. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 176. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 191. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 198. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 205. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 212. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 219. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 226. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 228. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 230. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 231. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 233. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 240. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 247. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 254. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 256. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 257. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 258. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 259. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 260. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 261. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 263. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 264. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 265. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 266. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 267. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 268. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 275. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 282. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 289. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 296. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 303. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 310. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 317. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 324. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY MEDICINES, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
• TABLE 331. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 332. HEART FAILURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 333. HEART FAILURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 334. HEART FAILURE THERAPEUTICS MARKET LICENSE & PRICING

The Global Heart Failure Therapeutics Market is forecasted to grow significantly, with a projected USD 23.98 billion in 2023 at a CAGR of 10.23% and expected to reach a staggering USD 48.13 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Heart Failure Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Heart Failure Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Medical Devices, Medicines, and Surgery. The Medical Devices is further studied across Bi-level positive air pressure device, Biventricular Pacemaker, Continuous Positive Air Pressure Device, Heart Pumps, Implantable Cardioverter-Defibrillators, and Implantable Left Ventricular Assist Device. The Medicines is further studied across Angiotensin II Receptor Blockers, Anticoagulant Medicines, Antiplatelet Medicines, Blood Pressure Maintaining Agents, Diuretics, Nitrates, and Statins. The Surgery is further studied across Cardiac Resynchronization, Coronary Artery Bypass Grafting, Coronary Revascularization, Heart Transplant, and Heart Valve Replacement. The Medicines commanded largest market share of 41.86% in 2022, followed by Surgery.

Based on Type, market is studied across Diagnosis and Prognosis. The Prognosis commanded largest market share of 63.52% in 2022, followed by Diagnosis.

Based on Stage, market is studied across Stage A, Stage B, Stage C, and Stage D. The Stage A commanded largest market share of 32.70% in 2022, followed by Stage C.

Based on End User, market is studied across Clinic, Hospital, and Medical Research Organization. The Hospital commanded largest market share of 52.76% in 2022, followed by Clinic.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 37.99% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Heart Failure Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Heart Failure Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Heart Failure Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Heart Failure Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Heart Failure Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Heart Failure Therapeutics Market?

6. What is the market share of the leading vendors in the Global Heart Failure Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Heart Failure Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Heart Failure Therapeutics Market, by Treatment, 2022 vs 2030
• 4.3. Heart Failure Therapeutics Market, by Type, 2022 vs 2030
• 4.4. Heart Failure Therapeutics Market, by Stage, 2022 vs 2030
• 4.5. Heart Failure Therapeutics Market, by End User, 2022 vs 2030
• 4.6. Heart Failure Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Cardiovascular Diseases Among Geriatric Population
    • 5.1.1.2. Growing Susceptibility to Heart Failure and Arrhythmia Owing to Changing Lifestyles
    • 5.1.1.3. Availability and Preferences of Early Diagnosis and Management for Heart Failure
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost and Reimbursement Issues Related to Heart Failure Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations and Development in the Heart Failure Therapeutics
    • 5.1.3.2. Ongoing Government Initiatives and Increasing Investments by Private Sectors
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns Related to Management of Heart Failure Condition
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Heart Failure Therapeutics Market, by Treatment

• 6.1. Introduction
• 6.2. Medical Devices
  • 6.2.1. Bi-level positive air pressure device
  • 6.2.2. Biventricular Pacemaker
  • 6.2.3. Continuous Positive Air Pressure Device
  • 6.2.4. Heart Pumps
  • 6.2.5. Implantable Cardioverter-Defibrillators
  • 6.2.6. Implantable Left Ventricular Assist Device
• 6.3. Medicines
  • 6.3.1. Angiotensin II Receptor Blockers
  • 6.3.2. Anticoagulant Medicines
  • 6.3.3. Antiplatelet Medicines
  • 6.3.4. Blood Pressure Maintaining Agents
  • 6.3.5. Diuretics
  • 6.3.6. Nitrates
  • 6.3.7. Statins
• 6.4. Surgery
  • 6.4.1. Cardiac Resynchronization
  • 6.4.2. Coronary Artery Bypass Grafting
  • 6.4.3. Coronary Revascularization
  • 6.4.4. Heart Transplant
  • 6.4.5. Heart Valve Replacement

7. Heart Failure Therapeutics Market, by Type

• 7.1. Introduction
• 7.2. Diagnosis
• 7.3. Prognosis

8. Heart Failure Therapeutics Market, by Stage

• 8.1. Introduction
• 8.2. Stage A
• 8.3. Stage B
• 8.4. Stage C
• 8.5. Stage D

9. Heart Failure Therapeutics Market, by End User

• 9.1. Introduction
• 9.2. Clinic
• 9.3. Hospital
• 9.4. Medical Research Organization

10. Americas Heart Failure Therapeutics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Heart Failure Therapeutics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Heart Failure Therapeutics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing